Novartis saw the highest growth of 1.24% in patent filings in April and 1.12% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.24% and grants by 1.01%. GlobalData’s DataBook provides a comprehensive analysis of Novartis’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Novartis has been focused on protecting inventions in Japan(JP) with 94 publications in Q2 2024
The Japan(JP) Patent Office dominates the patent filings and grants with nearly 23% filings and 19% grants. The Japan(JP), United States(US), China(CN), and European Patent Office(EPO) patent Office are among the top ten patent offices where Novartis is filings its patents. Among the top granted patent authorities, Novartis has 19% of its grants in Japan(JP), 17% in United States(US) and 10% in European Patent Office(EPO).
Roche and Johnson & Johnson could be the strongest competitors for Novartis
In terms of grant share, Novartis stands in fourth position among its competitors. Roche and Johnson & Johnson secured the top positions according to recent patent publication data.
Patents related to rare diseases and climate change lead Novartis's portfolio
Novartis has the highest number of patents in rare diseases followed by, climate change and healthtech. For rare diseases, nearly 61% of patents were filed and 51% of patents were granted in Q2 2024.
Ophthalmic devices related patents lead Novartis portfolio followed by prostate cancer, and multiple sclerosis
Novartis has highest number of patents in ophthalmic devices followed by prostate cancer, multiple sclerosis, petrochemicals, and rheumatoid arthritis. For ophthalmic devices, nearly 2% of patents were filed and 3% of patents were granted in Q2 2024.
For comprehensive analysis of Novartis's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
